Pancreatic Cancer Research

ResearcherNational Institute for Health and Care ResearchActive in the last 2 years

Animesh Acharjee

Matched on ORCID iD 0000-0003-2735-7010; OpenAlex author ID A5008573021. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 3 papers · 2025: none · 2026: 2 papers

Papers 8

  1. Linking Targeted Pancreatic Cancer Genes With Metabolic Disorders: A Cross-Species Translational Pathway. Last author DOI 10.1002/cam4.71775↗
  2. RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged Survival in Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.modpat.2026.101010↗
  3. Network dynamics and therapeutic aspects of mRNA and protein markers with the recurrence sites of pancreatic cancer. Co-author DOI 10.1016/j.heliyon.2024.e31437↗
  4. Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-24-0368↗
  5. High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment. First author DOI 10.3389/fimmu.2024.1360629↗
  6. Role of microbiota and microbiota-derived short-chain fatty acids in PDAC. Last author DOI 10.1002/cam4.5323↗
  7. Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer. Co-author DOI 10.1136/gutjnl-2022-329371↗
  8. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer. First author DOI 10.3389/fimmu.2021.643529↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Beat Gloor · 4 shared papers, 2021–2026 · strength 0.91
  2. Eva Karamitopoulou · 4 shared papers, 2021–2026 · strength 0.91
  3. Anna Silvia Wenning · 3 shared papers, 2023–2026 · strength 0.77
  4. Aurel A. Perren · 3 shared papers, 2023–2026 · strength 0.77
  5. Pauline Aeschbacher · 3 shared papers, 2023–2026 · strength 0.77
  6. Dipanwita Nath · 2 shared papers, 2024–2026 · strength 0.64
  7. Georgios V. Gkoutos · 2 shared papers, 2023–2024 · strength 0.50
  8. Hassan Sadozai · 2 shared papers, 2021–2024 · strength 0.41
  9. Shivan Sivakumar · 1 shared paper, 2026 · strength 0.36
  10. Konstantin Bräutigam · 1 shared paper, 2026 · strength 0.33
  11. Bernard Burke · 1 shared paper, 2024 · strength 0.26
  12. Hülya YILMAZ TEMEL · 1 shared paper, 2023 · strength 0.22
  13. Mirjam Schenk · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.